Results 201 to 210 of about 43,652 (215)

Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanoma. [PDF]

Cell Death Discov
Bartolomei L, Ciribilli Y, Brugnara S, Reggiani F, Moretta GM, Petito M, Marcaccini E, Ambrosio M, Mosci C, Pfeffer U, Amaro A, Monti P, Bisio A.   +12 more
europepmc   +1 more source

Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case report. [PDF]

ESMO Open
Smarsly D, Kreuzberg N, Langhorst C, Scheffler M, Siebolts U, Lennartz S, Koll P, Glaser AC, Franklin C.   +8 more
europepmc   +1 more source

Four Months of Exercise Intervention Improved Visuomotor, Functional and Cardiorespiratory Capacity in a Patient with Metastatic Uveal Melanoma. [PDF]

Reports (MDPI)
Mendes Wefelnberg M, Hennigfeld S, Simon M, Wawer Matos P, Heindl LM, Rokohl AC, Bröckelmann P, Baumann FT.   +7 more
europepmc   +1 more source

Expression of the programmed cell death ligand 1 (PD-L1) on uveal melanoma cells with Monosomy-3

, 2017
Aysegül Tura, Anna Kraus, Mahdy Ranjbar, Julia Lueke, Salvatore Grisanti   +4 more
openalex   +1 more source

Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening. [PDF]

Cancers (Basel)
Lubrano S, Cervantes-Villagrana RD, Arang N, Cardenas-Alcoser ES, Sato K, Cuesta-Margolles G, Paradis JS, Acosta M, Gutkind JS.   +8 more
europepmc   +1 more source

PERP-ing the points of contact between ER and plasma membrane: modulation of ER stress and apoptosis in uveal melanoma

, 2019
Luminita Paraoan
openalex   +1 more source

The Discovery of α-Adrenoceptor Antagonists as a Potential New Treatment Option for Uveal Melanoma. [PDF]

Biomolecules
He Y, Liu H, Hendgen-Cotta U, Rassaf T, Bechrakis NE, Berchner-Pfannschmidt U.   +5 more
europepmc   +1 more source

Progressive Vision Loss From Uveal Melanoma with Extraocular Extension: A Case Report. [PDF]

Am J Case Rep
Tupynambá APFC, Heller HL, Britto MFL, Macedo IF, Torres Junior JAG, Borges VLC, Vieira ABC, Ostrowski RB, Takano GHS, Oliveira LCGB.   +9 more
europepmc   +1 more source

Bispecific T-Cell Engagers, Cell Therapies, and Other Non-Checkpoint Immunotherapies for Metastatic Uveal Melanoma: A Narrative Review. [PDF]

J Clin Med
Kleinrok J, Pająk W, Pec J, Rusztyn K, Dolar-Szczasny J, Forma A, Teresiński G, Baj J.   +7 more
europepmc   +1 more source

Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study. [PDF]

Cancer Cell Int
Wu M, de Bruyn DP, Boers RG, Beasley AB, Hazelaar DM, Makrodimitris S, Boers JB, Vaarwater J, de Keizer ROB, Verdijk RM, Naus NC, Paridaens D, Wilting SM, Gray ES, van IJcken WFJ, Gribnau J, de Klein A, Brosens E, Kiliç E, Rotterdam Ocular Melanoma Studygroup.   +19 more
europepmc   +1 more source